Development of a vaccine for Chlamydia trachomatis: challenges and current progress

References

• Resnikoff S, Pascolini D, Etya’ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82(11):844–851.
   PubMed Web of Science ®Google Scholar
• Morré SA, Ossewaarde JM, Lan J, et al. Serotyping and genotyping of genital Chlamydia trachomatis isolates reveal variants of serovars Ba, G, and J as confirmed by omp1 nucleotide sequence analysis. J Clin Microbiol. 1998;36:345–351.
   PubMed Web of Science ®Google Scholar
• Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis. 2010;201 Suppl 2:S134–S155
   Google Scholar
• Geisler WM, Suchland RJ, Whittington WL, Stamm WE. The relationship of serovar to clinical manifestations of urogenital Chlamydia trachomatis infection. Sex Transm Dis. 2003;30(2):160–165.
   Web of Science ®Google Scholar
• Peipert JF. Clinical practice. Genital chlamydial infections. N Engl J Med. 2003;349(25):2424–2430.
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Global strategy for the prevention and control of sexually transmitted infections: 2006–2015: Breaking the chain of transmission. Geneva: World Health Organization; 2007.
   Google Scholar
• Hosenfeld CB, Workowski KA, Berman S, et al. Repeat infection with chlamydia and gonorrhoea among females: a systematic review of the literature. Sex Trans Dis. 2009;36:478–489.
   PubMed Web of Science ®Google Scholar
• Dean D, Suchland RJ, Stamm WE. Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. J Infect Dis. 2000;182:909–916.
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Global incidence and prevalence of selected curable sexually-transmitted infections – 2008. Geneva: World Health Organization; 2012.
   Google Scholar
• Torrone E, Papp J, Weinstock H; Centers for Disease Control and Prevention (CDC). Prevalence of Chlamydia trachomatis genital infection among persons aged 14–39 years – United States, 2007–2012. MMWR Morb Mortal Wkly Rep. 2014;63(38):834–838.
   PubMed Web of Science ®Google Scholar
• Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012;96(5):614–618.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global elimination of blinding trachoma. Geneva: World Health Organization; 1998. Available from: http://www.who.int/neglected_diseases/mediacentre/WHA_51.11_Eng.pdf. Accessed April 14, 2015.
   Google Scholar
• No authors listed. Alliance for the Global Elimination of Blinding Trachoma by the year 2020. Progress report on elimination of trachoma, 2013. Wkly Epidemiol Rec. 2014;89:421–428. English, French.
   Google Scholar
• Johnson RE, Newell WJ, Papp JR, et al. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections – 2002. MMWR Recomm Rep. 2002;51:1–38; quiz CE1-4.
   PubMedGoogle Scholar
• Brunham RC, Reckart ML. The arrested immunity hypothesis and the epidemiology of chalmydia control. Sex Trans Dis. 2008;35(1):53–54.
   PubMed Web of Science ®Google Scholar
• Abdelsamed H, Peters J, Byrne GI. Genetic variation in Chlamydia trachomatis and their hosts: impact on disease severity and tissue tropism. Future Microbiol. 2013;8(9):1129–1146.
   PubMed Web of Science ®Google Scholar
• Kari L, Whitmire WM, Olivares-Zavaleta N, et al. A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates. J Exp Med. 2011;208(11):2217–2213.
   Web of Science ®Google Scholar
• Kinnunen AH, Surcel HM, Lehtinen M, et al. HLA DQ alleles and interleukin-10 polymorphism associated with Chlamydia trachomatis-related tubal factor infertility: a case-control study. Hum Reprod. 2002;17:2071–2078.
   Web of Science ®Google Scholar
• Mei B, Luo Q, Du K, Huo Z, Wang F, Yu P. Association of MICA gene polymorphisms with Chalmydia trachomatis infection and related tubal pathology in infertile women. Hum Reprod. 2009;24:3090–3095.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Holland MJ, Makalo P, et al. The conjunctival microbiome in health and trachomatous disease: a case control study. Genome Med. 2014;6:99.
   PubMed Web of Science ®Google Scholar
• Aiyar A, Quayle AJ, Buckner LR, et al. Influence of the tryptophan-indole-IFNγ axis on human genital Chlamydia trachomatis infection: role of vaginal co-infections. Front Cell Infect Microbiol. 2014;4;72.
   Google Scholar
• Caldwell HD, Wood H, Crane D, et al. Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. J Clin Invest. 2003;111:1757–1769.
   PubMed Web of Science ®Google Scholar
• Brunelle BW, Nicholson TL, Stephens RS. Microarray-base genomic surveying of gene polymorphisms in Chlamydia trachomatis. Genome Biol. 2004;5:R42.
   Web of Science ®Google Scholar
• Carlson JH, Hughes S, Hogan D, et al. Polymorphisms in the Chlamydia trachomatis cytotoxin locus associated with ocular and genital isolates. Infect Immun. 2004;72:7063–7072.
   PubMed Web of Science ®Google Scholar
• Byrne GI. Chlamydia trachomatis strains and virulence: rethinking links to infection prevalence and disease severity. J Infect Dis. 2010;201 Suppl 2:S126–S133.
   Google Scholar
• van Duynhoven YT, Osserwaade JM, Derksen-Nawrocki RP, van der Meijden WI, van der Laar MJ. Chlamydia trachomatis genotypes: correlation with clinical manifestations of infection and patients’ characteristics. Clin Infect Dis. 1998,26:314–322.
   Web of Science ®Google Scholar
• Verweij SP, Lanjouw E, Bax CJ, et al. Serovar D and E of serogroup B induce highest serological responses in urogenital Chlamydia trachomatis infections. BMC Infect Dis. 2014;14:3.
   PubMed Web of Science ®Google Scholar
• Datta B, Njau F, Thalmann J, Haller H, Wagner AD. Differential infection outcome of Chlamydia trachomatis in human blood monocytes and monocyte-derived dendritic cells. BMC Microbiol. 2014;14:209.
   Web of Science ®Google Scholar
• Zhu S, Feng Y, Chen J, et al. Identification of linear B-cell epitopes within Tarp of Chlamydia trachomatis. J Pept Sci. 2014;20(12):916–922.
   Web of Science ®Google Scholar
• Gauliard E, Ouellette SP, Rueden KJ, Ladant D. Characterization of interactions between inclusion membrane proteins from Chlamydia trachomatis. Front Cell Infect Microbiol. 2015;5:13.
   Web of Science ®Google Scholar
• Carlson JH, Whitmire WM, Crane DD, et al. The Chlamydia trachomatis plasmid is a transcriptional regulator of chromosomal genes and a virulence factor. Infect Immun. 2008;76(6):2273–2283.
   Web of Science ®Google Scholar
• Song L, Carlson JH, Whitmire WM, et al. Chlamydia trachomatis plasmid-encoded Pgp4 is a transcriptional regulator of virulence-associated genes. Infect Immun. 2013;81:636–644.
   PubMed Web of Science ®Google Scholar
• Li Z, Chen D, Zhong Y, Wang S, Zhong G. The chlamydial plasmid-encoded protein pgp3 is secreted into the cytosol of Chlamydia-infected cells. Infect Immun. 2008;76(8):3415–3428.
   PubMed Web of Science ®Google Scholar
• Igietseme JU, Omosun Y, Partin J, et al. Prevention of Chlamydia-induced infertility by inhibition of local caspase activity. J Infect Dis. 2013;207(7):1095–1104.
   Web of Science ®Google Scholar
• Kari L, Watkins HS, Randall LB, et al. Inactivating pgp3 is sufficient to reproduce the attenuation associated with the loss of the complete Chlamydia trachomatis plasmid in macaques. Thirteenth International Symposium on Human Chlamydial Infections (ISHCI), 2014 ASIOLMAR Conference Grounds in Pacific Grove California; June 22–27, 2014.
   Google Scholar
• Seth-Smith HM, Harris SR, Persson K, et al. Co-evolution of genomes and plasmids within Chlamydia trachomatis and the emergence in Sweden of a new variant strain. BMC Genomics. 2009;10:239.
   Web of Science ®Google Scholar
• Song L, Carlson JH, Zhou B, et al. Plasmid-mediated transformation tropism of chlamydial biovars. Pathog Dis. 2014;70:189–193.
   Web of Science ®Google Scholar
• Porcella SF, Carlson JH, Sturdevant DE, et al. Transcriptional profiling of human epithelial cells infected with plasmid-bearing and plasmid-deficient Chlamydia trachomatis. Infect Immun. 2015;83(2):534–543.
   PubMed Web of Science ®Google Scholar
• Natividad A, Wilson J, Koch O, et al. Risk of trachomatous scarring and trichiasis in Gambians varies with SNP haplotypes at the interferon-gamma and interleukin-10 loci. Genes Immun. 2005;6:332–340.
   Web of Science ®Google Scholar
• Natividad A, Holland MJ, Rockett KA, et al. Susceptibility to sequelae of human ocular chlamydial infection associated with allelic variation in IL10 cis-regulation. Hum Mol Genet. 2008;17(2):323–329.
   Web of Science ®Google Scholar
• Natividad A, Hanchard N, Holland MJ, et al. Genetic variation at the TNF locus and the risk of severe sequelae of ocular Chlamydia trachomatis infection Gambians. Genes Immun. 2007;8:288–295.
   PubMed Web of Science ®Google Scholar
• Hu VH, Weiss HA, Ramadhani AM, et al. Innate immune responses and modified extracellular matrix regulation characterize bacterial infection and cellular/connective tissue changes in scarring trachoma. Infect Immun. 2012;80:121–130.
   Web of Science ®Google Scholar
• Natividad A, Freeman TC, Jeffries D, et al. Human conjunctival transcriptome analysis reveals the prominence of innate defense in Chlamydia trachomatis infection. Infect Immun. 2010;78:4895–4911.
   Web of Science ®Google Scholar
• Roberts CH, Molina S, Makalo P, et al. Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3. PLoS Negl Trop Dis. 2014;8(3):e2744.
   Web of Science ®Google Scholar
• Ohman H. Immunogenetic Risk Factors of Chlamydia-Induced Tubal Factor Infertility [PhD thesis]. Oulu, Helsinki: University of Oulu, University of Helsinki; 2012.
   Google Scholar
• King M, Poya H, Rao J, et al. CXCL13 expression in Chlamydia trachomatis infection of the female reproductive tract. Drugs Today (Barc). 2009;45 Suppl B:125–134.
   Web of Science ®Google Scholar
• Jiang J, Karimi O, Ouburg S, et al. Interruption of the CXCL13-CXCR5 axis increases upper genital tract pathology and activation of NKT cells following chlamydial genital infection. PLoS One. 2012;7(11):e47487.
   PubMed Web of Science ®Google Scholar
• Mozzato-Chamay N, Mahdi OS, Jallow O, Mabey DC, Bailey RL, Conway DJ. Polymorphisms in candidate genes and risk of scarring trachoma in a Chlamydia trachomatis – endemic population. J Infect Dis. 2000;182(5):1545–1548.
   Web of Science ®Google Scholar
• Wang C, Tang J, Geisler WM, Crowley-Nowick PA, Wilson CM, Kaslow RA. Human leukocyte antigen and cytokine gene variants as predictors of recurrent Chlamydia trachomatis infection in high-risk adolescents. J Infect Dis. 2005;191(7):1084–1092.
   PubMed Web of Science ®Google Scholar
• Dong Q, Brulc JM, Iovieno A, et al. Diversity of bacteria at healthy human conjunctiva. Invest Ophthalmol Vis Sci. 2011;52(8):5408–5413.
   PubMed Web of Science ®Google Scholar
• Ravel J, Gajer P, Abdo Z, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2011;108 Suppl 1:4680–4687.
   Google Scholar
• Byrne GI, Carlin JM, Merkert TP, Arter DL. Long term effects of gamma interferon on chlamydia-infected host cells: microbiocidal activity follows microbistasis. Infect Immun. 1989;57:1318–1320.
   PubMed Web of Science ®Google Scholar
• Byrne GI, Lehmann LK, Landry GJ. Induction of tryptophan catabolism is the mechanism for gamma-interferon mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect Immun. 1986;53:347–351.
   PubMed Web of Science ®Google Scholar
• Beatty WL, Belanger TA, Desai AA, Morrison RP, Byrne GI. Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence. Infect Immun. 1994;62:3705–3711.
   PubMed Web of Science ®Google Scholar
• Brunham RC, Rey-Ladino J. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol. 2005;5:149–161.
   PubMed Web of Science ®Google Scholar
• Hogan RJ, Mathews SA, Mukhopadhyay S, Summersgill JT, Timms P. Chlamydial persistence: beyond the biphasic paradigm. Infect Immun. 2004;72:1843–1855.
   PubMed Web of Science ®Google Scholar
• Wyrick PB. Chlamydia trachomatis persistence in vitro: an overview. J Infect Dis. 2010;201 Suppl 2:S88–S95.
   Google Scholar
• Mpiga P, Ravaoarinoro M. Chlamydia trachomatis persistence: an update. Microbiol Res. 2006;161(1):9–19.
   Google Scholar
• den Hartog JE, Land JA, Stassen FR, Kessels AG, Bruggeman CA. Serological markers of persistent C. trachomatis infections in women with tubal factor subfertility. Hum Reprod. 2005;20:986–990.
   PubMed Web of Science ®Google Scholar
• Cevallos V, Witcher JP, Melese M, et al. Association of conjunctival bacterial infection and female sex in cicatricial trachoma. Invest Opthamol Vis Sci. 2012;53:5208–5212.
   Web of Science ®Google Scholar
• Garland SM, Malatt A, Tabrizi S, et al. Chlamydia trachomatis conjunctivitis. Prevalence and association with genital tract infection. Med J Aust. 1995;162:363–366.
   PubMed Web of Science ®Google Scholar
• Sulis G, Urbinati L, Franzoni A, Gargiulo F, Carvalho AC, Matteelli A. Chlamydia trachomatis conjunctivitis in a male teenager: a case report. Infez Med. 2014;22(2):140–143.
   Google Scholar
• Sasaki-Imamura T, Yoshida Y, Suwabe K, Yoshimura F, Kato H. Molecular basis of indole production catalysed by tryptiphanase in the genus Prevotella. FEMS Microbiol Lett. 2011;322:51–59.
   Web of Science ®Google Scholar
• Mirmonsef P, Krass L, Landay A, Spear GT. The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract. Curr HIV Res. 2012;10(3):202–210.
   PubMed Web of Science ®Google Scholar
• Mitchell C, Balkus JE, Fredricks D, et al. Interaction between lactobacilli, bacterial vaginosis associated bacteria, and HIV Type 1 RNA and DNA Genital shedding in US and Kenyan women. AIDS Res Hum Retroviruses. 2013;29(1):13–19.
   Web of Science ®Google Scholar
• Sha BE, Zariffard MR, Wang QJ, et al. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J Infect Dis. 2005;191(1):25–32.
   Web of Science ®Google Scholar
• Mastromarino P, Di Pietro M,Schiavoni G, Nardis C, Gentile M, Sessa R. Effects of vaginal lactobacilli in Chlamydia trachomatis infection. Int J Med Microbiol. 2014;304(5–6):654–661.
   PubMed Web of Science ®Google Scholar
• Gong Z, Luna Y, Yu P, Fan H. Lactobacilli inactivate Chlamydia trachomatis through lactic acid but not H2O2. PLoS One. 2014;9(9):e107758.
   Web of Science ®Google Scholar
• Brotman RM, Ravel J, Bavoil PM, Gravitt PE, Ghanem KG. Microbiome, sex hormones, and immune responses in the reproductive tract: challenges for vaccine development against sexually transmitted infections. Vaccine. 2014;32:1543–1552.
   PubMed Web of Science ®Google Scholar
• Ferreira RB, Antunes LC, Finlay BB. Should the human microbiome be considered when developing vaccines? PLoS Pathog. 2010;6:e1001190.
   PubMed Web of Science ®Google Scholar
• Gottlieb SL, Low N, Newman LM, Bolan G, Kamb M, Broutet N. Toward global prevention of sexually transmitted infections (STIs): the need for STI vaccines. Vaccine. 2014;32:1527–1535.
   PubMed Web of Science ®Google Scholar
• de Visser RO, Badcock PB, Rissel C, et al. Safer sex and condom use: findings from the Second Australian Study of Health and Relationships. Sex Health. 2014;11(5):495–504.
   PubMed Web of Science ®Google Scholar
• Sonnenberg P, Clifton S, Beddows S, et al. Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal). Lancet. 2013;382(9907):1795–1806.
   PubMed Web of Science ®Google Scholar
• Low N, Bender N, Nartey L, Shang A, Stephenson JM. Effectiveness of chlamydia screening: systematic review. Int J Epidemiol. 2009;38:435–448.
   Web of Science ®Google Scholar
• Regan DG, Wilson DP, Hocking JS. Coverage is the key for effective screening of Chlamydia trachomatis in Australia. JID. 2008;198(3):349–358.
   Web of Science ®Google Scholar
• Brunham RC, Rappuoli R. Chlamydia trachomatis control requires a vaccine. Vaccine. 2013;31(15):1892–1897.
   PubMed Web of Science ®Google Scholar
• Walker J, Tabrizi SN, Fairley CK, et al. Chlamydia trachomatis incidence and re-infection among young women – behavioural and microbiological characteristics. PloS One. 2012;7(5):e37778.
   Web of Science ®Google Scholar
• Kong FY, Tabrizi SN, Law M, et al. Azithromycin versus doxycycline for the treatment of genital chlamydia infection: a meta-analysis of randomized controlled trials. Clin Infect Dis. 2014;59(2):193–205.
   Web of Science ®Google Scholar
• Liu B, Guy R, Donovan B, Kaldor JM. Chlamydia trachonatis re-infections in a population-based cohort of women. Sex Trans Infect. 2013;89(1):45–50.
   Web of Science ®Google Scholar
• Mabey DC, Hu V, Bailey RL, Burton MJ, Holland MJ. Towards a safe and effective chlamydial vaccine: Lessons from the eye. Vaccine. 2014;32:1572–1578.
   PubMed Web of Science ®Google Scholar
• Bailey R, Duong T, Carpenter R, Whittle H, Mabey D. The duration of human ocular Chlamydia trachomatis infection is age dependent. Epidemiol Infect. 1999;123:479–486.
   PubMed Web of Science ®Google Scholar
• Grassly NC, Ward ME, Ferris S, Mabey DC, Bailey RL. The natural history of trachoma infection and disease in a Gambian cohort with frequent follow-up. PLoS Negl Trop Dis. 2008;2(12):e341.
   PubMed Web of Science ®Google Scholar
• Molano M, Meijer CJ, Weiderpass E, et al. The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study. J Infect Dis. 2005;191(6):907–916.
   PubMed Web of Science ®Google Scholar
• Geisler WM. Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies. J Infect Dis. 2010;201 Suppl 2:S104–S113.
   Google Scholar
• Ness RB, Soper DE, Richter HE, et al. Chlamydia antibodies, Chlamydia heat shock protein, and adverse sequelae after pelvic inflammatory disease: the PID Evaluation and Clinical Health (PEACH) Study. Sex Transm Dis. 2008;35(2):129–135.
   Web of Science ®Google Scholar
• Stephens RS. The cellular paradigm of chlamydial pathogenesis. Trends Microbiol. 2003;11:44–51.
   PubMed Web of Science ®Google Scholar
• Rasmussen SJ, Eckmann L, Quayle AJ, et al. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J Clin Invest. 1997;99:77–87.
   PubMed Web of Science ®Google Scholar
• Darville T, Hiltke TJ. Pathogenesis of genital tract disease due to Chalmydia trachomatis. J Infect Dis. 2010;201 Suppl 2:S114–S125.
   Google Scholar
• Johnson RM. Murine oviduct epithelial cell cytokine responses to Chlamydia muridarum infection include interleukin-12-p70 secretion. Infect Immun. 2004;72:3951–3960.
   Web of Science ®Google Scholar
• Bucholz KR, Stephens RS. Activation of the host cell proinflammatory interleukin-8 response by Chlamydia trachomatis. Cell Microbiol. 2006;8:1768–1779.
   Web of Science ®Google Scholar
• Roan NR, Starnbach MN. Immune-mediated control of Chlamydia infection. Cell Microbiol. 2008;10:9–19.
   PubMed Web of Science ®Google Scholar
• Agrawal T, Bhengraj AR, Vats V, Salhan S, Mittal A. Expression of TLR 2, TLR 4 and iNOS in cervical monocytes of Chlamydia trachomatis-infected women and their role in host immune response. Am J Reprod Immunol. 2011;66(6):534–543.
   Web of Science ®Google Scholar
• Wan C, Latter JL, Amirshahi A, et al. Progesterone activates multiple innate immune pathways in Chlamydia trachomatis-infected endocervical cells. A J Reprod Immunol. 2014;71:165–177.
   Web of Science ®Google Scholar
• Wira CR, Rodriguez-Garcia M, Patel MV. The role of sex hormones in immune protection of the female reproductive tract. Nat Rev Immunol. 2015;15:217–230.
   PubMed Web of Science ®Google Scholar
• Hafner LM, Cunningham K, Beagley KW. Ovarian steroid hormones: effects on immune responses and Chlamydia trachomatis infections of the female genital tract. Mucosal Immunol. 2013;6:859–875.
   PubMed Web of Science ®Google Scholar
• Burton MJ, Rajak SN, Bauer J, et al. Conjunctival transcriptome in scarring trachoma. Infect Immun. 2011;79:499–511.
   Web of Science ®Google Scholar
• Burton MJ, Ramadhani A, Weiss HA, et al. Active trachoma is associated with increased conjunctival expression of IL17A and profibrotic cytokines. Infect Immun. 2011;79:4977–4983.
   Web of Science ®Google Scholar
• Hu VH, Holland MJ, Burton MJ. Trachoma: protective and pathogenic ocular immune responses to Chlamydia trachomatis. PLoS Neglected Trop Dis. 2013;7(2):e2020.
   PubMed Web of Science ®Google Scholar
• Burton MJ, Bailey RL, Jeffries D, Mabey DC, Holland MJ. Cytokine and fibrogenic gene expression in the conjunctivas of subjects from a Gambian community where trachoma is endemic. Infect Immun. 2004;72:7352–7356.
   Web of Science ®Google Scholar
• Bobo L, Novak N, Mkocha H, Vitale S, West S, Quinn TC. Evidence for a predominant proinflammatory conjunctival cytokine response in individuals with trachoma. Infect Immun. 1996;64:3273–3279.
   PubMed Web of Science ®Google Scholar
• Ault KA, Kelly KA, Ruther PE, et al. Chlamydia trachomatis enhances the expression of matrix metalloproteinases in an in vitro model of the human fallopian tube infection. Am J Obstet Gynecol. 2002;187(5):1377–1383.
   Web of Science ®Google Scholar
• Ramsey KH, Sigar IM, Schripsema JH, Shaba N, Cohoon KP. Expression of matrix metalloproteinases subsequent to urogenital Chlamydia muridarum infection of mice. Infect Immun. 2005;73(10):6962–6973.
   Web of Science ®Google Scholar
• Refaat B, Al-Azemi M, Geary I, Eley A, Ledger W. Role of activins and inducible nitric oxide in the pathogenesis of ectopic pregnancy in patients with or without Chlamydia trahomatis infection. Clin Vaccine Immunol. 2009;16(10):1493–1503.
   Google Scholar
• Humphrys MS, Creasy T, Sun Y, et al. Simultaneous transcriptional profiling of bacteria and their host cells. PLoS One. 2013;8(12):e80597.
   Web of Science ®Google Scholar
• Hafner LM. Pathogenesis of fallopian tube damage caused by Chlamydia trachomatis infections. Contraception. Epub 2015 January 13.
   Google Scholar
• León B, Ballesteros-Tato A, Misra RS, Wojciechowski W, Lund FE. Unraveling effector functions of B cells during infection: the hidden world beyond antibody production. Infect Disord Drug Targets. 2012;12(3):213–221.
   Google Scholar
• Lu C, Holland MJ, Gong S, et al. Genome-wide identification of Chlamydia trachomatis antigens associated with trachomatous trichiasis. Ivest Opthamol Vis Sci. 2012;53:2551–2559.
   Web of Science ®Google Scholar
• Li LX, McSorley SJ. B cells enhance antigen-specific CD4 T cell priming and prevent bacteria dissemination following Chlamydia muridarum genital tract infection. PLoS Pathog. 2013;9:e1003707.
   Web of Science ®Google Scholar
• Li LX, McSorley SJ. A re-evaluation of the role of B cells in protective immunity to Chlamydia infection. Immunol Lett. 2015;164:88–93.
   PubMed Web of Science ®Google Scholar
• Drolet JP, Frangie H, Guay J, Hajoui O, Hamid Q, Mazer BD. B lymphocytes in inflammatory airway diseases. Clin Exp Allergy. 2010;40(6):841–849.
   Web of Science ®Google Scholar
• Townsend MJ, Monroe JG, Chan AC. B-cell targeted therapies in human autoimmune diseases: an updated perspective. Immunol Rev. 2010;237(1):264–283.
   PubMed Web of Science ®Google Scholar
• Su H, Feizler K, Caldwell HD, Morrison RP. Chlamydia trachomatis genital tract infections of antibody-deficient gene knockout mice. Infect Immun. 1997;65:1993–1999.
   PubMed Web of Science ®Google Scholar
• Gondek DC, Roan NR, Starnbach MN. T cell responses in the absence of IFN-gamma exacerbate uterine infection with Chlamydia trachomatis. J Immunol. 2009;183:1313–1319.
   PubMed Web of Science ®Google Scholar
• Johansson M, Schön K, Ward M, Lycke N. Genital tract infection with Chlamydia trachomatis fails to produce protective immunity in gamma-interferon receptor-deficient mice despite a strong local immunoglobulin A response. Infect Immun. 1997;65:1032–1044.
   PubMed Web of Science ®Google Scholar
• Davila SJ, Olive AJ, Starnbach MN. Integrin α4β1 is necessary for CD4+ T cell-mediated protection against genital Chlamydia trachomatis infection. J Immunol. 2014;192:4284–4293.
   Web of Science ®Google Scholar
• Johansson M, Lycke N. Immunological memory in B-cell-deficient mice conveys long-lasting protection against genital tract infection with Chlamydia trachomatis by rapid recruitment of T cells. Immunology. 2001;102:199–208.
   Web of Science ®Google Scholar
• Mi S, Li Z, Yang HZ, et al. Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta-1 dependent and -independent mechanisms. J Immunol. 2011;187:3003–3014.
   PubMed Web of Science ®Google Scholar
• Springall R, Amezcua-Guerra LM, Gonzalez-Pacheco H, et al. Interferon-gamma increases the ratio of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in peripheral monocytes from patients with coronary artery disease. PLoS One. 2013;8(8):e72291.
   Web of Science ®Google Scholar
• Jha R, Srivastava P, Salhan S, et al. Spontaneous secretion of interleukin-17 and -22 by human cervical cells in Chlamydia trachomatis infection. Microbes Infect. 2011;13(2):167–178.
   Web of Science ®Google Scholar
• Agrawal T, Vats V, Salhan S, Mital A. Mucosal and peripheral immune responses to chlamydial heat shock protein in women infected with Chlamydia trachomatis. Clin Exp Immunol. 2007;148:461–468.
   Web of Science ®Google Scholar
• Öhman H, Natividad A, Bailey R, et al. Contribution of IL-12A and IL-12B polymorphisms to Chlamydia trachomatis-specific cell- mediated immune responses. Scand J Immunol. 2015;81(3):209–213.
   PubMed Web of Science ®Google Scholar
• O’Meara CP, Armitage CW, Harvie MC, Timms P, Lycke NY, Beagley KW. Immunization with a MOMP-based vaccine protects against a pulmonary Chlamydia challenge and identifies a disconnection between infection and pathology. PLoS One. 2013;8(4):e61962.
   PubMed Web of Science ®Google Scholar
• Hafner LM, Timms P. Chlamydia. In: Stanberry LR, Rosenthal SL, editors. Sexually Transmitted Diseases. 2nd Edition. Waltham: Elsevier; 2013:369–410.
   Google Scholar
• Morrison SG, Morrison RP. A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection. J Immunol. 2005;175(11):7536–7542.
   PubMed Web of Science ®Google Scholar
• Farris CM, Morrison RP. Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model. Infect Immun. 2011;79(3):986–996.
   PubMed Web of Science ®Google Scholar
• Carey AJ, Cunningham KA, Hafner LM, Timms P, Beagley KW. Effects of inoculating dose on the kinetics of Chlamydia muridarum genital infection in female mice. Immunol Cell Biol. 2009;87(4):337–343.
   Web of Science ®Google Scholar
• Grayston JT, Woolridge RL, Wang SP, et al. Field studies of protection from infection by experimental trachoma virus vaccine in preschool-aged children on Taiwan. Proc Soc Exp Biol Med. 1963;112:589–595.
   PubMed Web of Science ®Google Scholar
• Geisler WM, Wang C, Morrison SG, Black CM, Bandea CI, Hook EW 3rd. The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment. Sex Trans Dis. 2008;35(2):119–123.
   Web of Science ®Google Scholar
• Geisler WM, Lensing SY, Press CG, Hook EW 3rd. Spontaneous resolution of genital Chlamydia trachomatis infection in women and protection from reinfection. J Infect Dis. 2013;207(12):1850–1856.
   Web of Science ®Google Scholar
• Hafner LM, Wilson DP, Timms P. Development status and future prospects for a vaccine against Chlamydia trachomatis infection. Vaccine. 2014;32(14):1563–1571.
   PubMed Web of Science ®Google Scholar
• Barker CJ, Beagley KW, Hafner LM, Timms P. In silico identification and in vivo analysis of a novel T-cell antigen from Chlamydia, NrdB. Vaccine. 2008;26:1285–1296.
   PubMed Web of Science ®Google Scholar
• Finco O, Frigimelica E, Buricchi F, et al. Approaches to discover T- and B-cell antigens of the intracellular pathogens applied to the design of Chlamydia trachomatis vaccine. Proc Natl Acad Sci U S A. 2011;108:9969–9974.
   PubMed Web of Science ®Google Scholar
• Coler RN, Bhatia A, Maisonneuve JF, et al. Identification and characterisation of novel recombinant vaccine antifens for immunization against genital Chlamydia trachomatis. FEMS Immunol Med Microbiol. 2009;55:258–270.
   PubMedGoogle Scholar
• Wang J, Chen I, Chen F, et al. A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice. Vaccine. 2009;27:2967–2980.
   PubMed Web of Science ®Google Scholar
• Murthy AK, Cong Y, Murphey C, et al. Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele. Infect Immun. 2006;74:6722–6729.
   Web of Science ®Google Scholar
• Yu H, Jiang X, Shen C, et al. Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells. Infect Immun. 2010;78(5):2272–2782.
   PubMed Web of Science ®Google Scholar
• Follmann F, Olsen AW, Jensen KT, Hansen PR, Andersen P, Theisen M. Antigenic profiling of a Chlamydia trachomatis gene expression library. J Infect Dis. 2008;197:897–905.
   PubMed Web of Science ®Google Scholar
• Olsen AW, Follmann F, Erneholm K, Rosenkrands I, Andersen P. Protection Against Chlamydia trachomatis Infection and Upper Genital Tract Pathological Changes by Vaccine-Promoted Neutralizing Antibodies Directed to the VD4 of the Major Outer Membrane Protein. J Infect Dis. Epub 2015 March 6.
   Google Scholar
• Wang Y, Kahane S, Cutcliffe LT, Skilton RJ, Lambden PR, Clarke IN. Development of a transformation system for Chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector. PLoS Pathog. 2011;7(9):e1002258.
   PubMed Web of Science ®Google Scholar
• Ramsey KH, Schripsema JH, Smith BJ, et al. Plasmid CDS5 influences infectivity and virulence in a mouse model of Chlamydia trachomatis urogenital infection. Infect Immun. 2014;82(8):3341–3349.
   Web of Science ®Google Scholar
• Nguyen BD, Valdivia RH. Forward genetic approaches in Chlamydia trachomatis. J Vis Exp. 2013;(80):e50636.
   Web of Science ®Google Scholar
• Kari L, Goheen MM, Randall LB, et al. Generation of targeted Chlamydia trachomatis null mutants. Proc Natl Acad Sci U S A. 2011;108(17):7189–7193.
   Web of Science ®Google Scholar
• Snavely EA, Kokes M, Dunn JD, et al. Reassessing the role of the secreted protease CPAF in Chlamydia trachomatis infection through genetic approaches. Pathog Dis. 2014;71(3):336–351.
   Web of Science ®Google Scholar
• Kari L, Southern TR, Downey CJ, et al. Chlamydia trachomatis polymorphic membrane protein D is a virulence factor involved in early host-cell interactions. Infect Immun. 2014;82(7):2756–2762.
   Web of Science ®Google Scholar
• Andrew DW, Hafner LM, Beagley KW, Timms P. Partial protection against chlamydial reproductive tract infection by a recombinant major outer membrane protein/CpG/cholera toxin intranasal vaccine in the guinea pig Chlamydia caviae model. J Reprod Immunol. 2011;91(1–2):9–16.
   PubMed Web of Science ®Google Scholar
• Wali S, Gupta R, Veselenak RL, et al. Use of a Guinea pig-specific transcriptome array for evaluation of protective immunity against genital chlamydial infection following intranasal vaccination in Guinea pigs. PLoS One. 2014;9(12):e114261.
   Web of Science ®Google Scholar
• Neuendorf E, Gajer P, Bowlin AK, et al. Chlamydia caviae infection alters abundance but not composition of the guinea pig vaginal microbiota. Pathog Dis. 2015;73(4).
   Web of Science ®Google Scholar
• Yeruva L, Spencer N, Bowlin AK, Wang Y, Rank RG. Chlamydial infection of the gastrointestinal tract: a reservoir for persistent infection. Pathog Dis. 2013;68(3):88–95.
   PubMed Web of Science ®Google Scholar
• Rank RG, Yeruva L. Hidden in plain sight: chlamydial gastrointestinal infection and its relevance to persistence in human genital infection. Infect Immun. 2014;82(4):1362–1371.
   PubMed Web of Science ®Google Scholar